ION363

ION363 · Ionis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ION363, covering 2026-02-18 to 2026-02-18. Get the full timeline:

Most recent: Clinical Trial Update: FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS) [Phase 3]

See pricing